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The delayed-type hypersensitivity (DTH)' skin response elicited in immunized
hosts reflects discrete, sequentialevents in different anatomical compartments (1-3).
After immunization, antigen-specific T cells are activated and clonally expanded
in draining lymphoid tissues. Activated antigen-specific T cells recirculating in the
blood are mobilized to the skin if the antigen (ag) is reinjected. Once restimulated
by accessory cells, T cells secrete a range of interleukins, including IFN-'Y and IL-2
that promote local recruitment of myelomonocytic cells from blood and alter the
phenotype of surrounding endothelial cells, fibroblasts and keratinocytes (4-7). In-
duction of a DTH response may be either protective (7, 8) or deleterious (9) de-
pending on the final balance between eradication ofan infective organism and damage
to host tissues.
The type 3 complement receptor (CR3) plays and important role in leukocyte
adhesion and recruitment to an immunologically nonspecific inflammatory stimulus
(10). The CR3 belongs to the leukocyte function-associated 1 (LFA-1) family of sur-
face receptors (11) and forms part ofthe integrin superfamily of cell adhesion mole-
cules (12) which mediate a wide range of cell-cell and cell-substratum interactions
(13). Human patients deficient in the LFA-1 family of molecules, namely LFA-1, CR3,
and p150/95, display defective leukocyte adhesion and a decreased ability to recruit
myelomonocytic cells to extravascular sites (14, 15), but since all three molecules are
absent or reduced on the surface of leukocytes, it is not possible to ascribe distinct
functions to individual LFA-1 family members. A murine model in which CR3 function
is perturbed by the use of a specific mAb, 5C6 (10), has allowed the assessment of
the contribution of CR3 alone during inflammatory responses within the intact an-
imal. In this paper we have examined the extent to which T cell-dependent inflam-
mation induced by specific ag challenge in sensitized mice, or by adoptive transfer
in naive, syngeneic mice is inhibitable by an mAb (5C6) directed specifically to CR3.
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Materials and Methods
Mice.
￿
8-wk-old C57/BL6 female mice were obtained either from the Sir William Dunn
School of Pathology, Oxford or the specific pathogen-free unit of the Institut Pasteur, Paris,
France.
Immunization and Treatment ofMice.
￿
SRBC in Alsevers solution (Gibco Laboratories, Paisley,
Scotland) were washed three times in Dulbeccds A PBS and resuspended in sterile normal
saline. 105 SRBC were injected intravenously into the tail vein. Mice were immunized with
3 x 106 viable BCG organisms (Insitut Pasteur) (16) by subcutaneous injection in both hind
footpads.
Assay ofthe DTH to SRBC.
￿
4 d after immunization mice were tested for DTH by an anti-
genic challenge of 10' or 108 SRBC injected subcutaneously in a volume of 50 tcl into the
right hind footpad . Footpad swelling was measured at a range of times with a dial gauge cal-
iper and the measurement of the uninjected footpad was subtracted from that of the chal-
lenged footpad. Footpads were subsequently removed and fixed in formol-saline. The wax-
embedded footpads were then sectioned and stained with hematoxylin and eosin. The local
adoptive transfer of the DTH reaction in syngeneic naive mice was performed as described
(17). Briefly, 4 d after immunization, mice received 50 IU of heparin. Heparinized blood
was collected 15 min later, diluted and used as a source of SRBC-sensitized T cells. This
was then mixed with either SRBC or unrelated ag and injected into one hind footpad of
naive, syngeneic recipients and the increase in footpad thickness was examined 14-18 h later.
Footpads were processed for histological examination as above.
Assay ofthe Adoptively Transferred Inflammatory Response to Tuberculin.
￿
4-6 d after BCG immu-
nization of the footpads, draining lymph nodes were removed, teased apart, and the single
cell suspension was used as a source of tuberculin-reactive T lymphocytes. 1 .5 x 10' cells
were mixed with 50 Irg of tuberculin and injected in a volume of 1 ml into the peritoneal
cavity of naive, syngeneic mice (18) . Peritoneal cells were harvested 48 h later, counted, and
cytospin preparations were then examined immunocytochemically by an indirect im-
munoperoxidase technique (19) to allow an accurate assessment of the different cells recov-
ered. Specifically, the proportion of macrophages (W~) was assessed by staining cytospin
preparations for the F4/80 ag (20) with a polyclonal rabbit antiserum prepared against purified
murine F4/80 ag by Dr. Pietro Dri in this laboratory. This permitted the specific staining
of M(k even when labeled with the 5C6 rat mAb.
The Effects ofmAb 5C6 on Expression ofDTH.
￿
5C6, a rat IgG2b mAb directed against the
murine CR3, was prepared and purified as described (10). 1 mg ofIgG was injected intrave-
nously either at the time of ag challenge or up to 6 h later and the effects were compared
with controls in which either buffer alone or a control rat IgG2a mAb 7/4 (21) restricted
to murine myelomonocytic cells, and with a similar site number to 5C6 or the F(ab')2 frag-
ment of 5C6 that has no in vivo activity (10) were injected. In experiments where local injec-
tion ofsensitized T cells and ag was used to adoptively transfer DTH, 5C6, or a control prep-
aration was injected intravenously to donor mice at the time of immunization to assess possible
effects on the development of ag-reactive T cells. Recipients were injected with mAbs intrave-
nously at the time oflocal transfer to influence systemic delivery of inflammatory cells. Alter-
natively, the transferred blood cells were preincubated with mAb and then washed by cen-
trifugation before local injection.
The Persistence ofmAb after a Single Intravenous Injection.
￿
The adequacy of circulating 5C6
IgG was assessed in two ways. First, serial blood samples were taken at times from 1 h to
4 d after a single injection of 1 mg i .v. The serum was then diluted in Iscove's medium (Flow
Laboratories, Paisley, Scotland) with 5olo FCS and 4-d thioglycollate-elicited M4~ were then
incubated in the diluted serum before measurement of adhesion to bacterial plastic as de-
scribed (10). 4 d after injection, a 1 :10 dilution of the sampled serum still inhibited adhesion
to plastic by >85%. In addition, the degree of mAb binding to blood leukocytes, peritoneal
cells, and bone marrow cells was assessed at 1, 4, 24, 48, and 72 h after a single intravenous
injection of FITC-5C6, by fluorescence analysis on a FAGS II apparatus (Becton Dickinson
& Co., Mountain View, CA). Saturation binding to myelomonocytic cells alone was seen,
and persisted for the duration of the experiment.ROSEN ET AL .
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Assay of the Half-Life of5C6 IgG and F(ab')z in the Circulation .
￿
Mice were injected i.v. with
3,000 U of intact IgG or F(ab')z . 50 g1 of blood were collected from the tail veins at 10 min,
and at 2, 4, 8, and 24 h after injection . Serial dilutions of this blood were assayed for binding
activity as described (10) . Bindingwas defined in an indirectRIA to adherent glutaradehyde-
fixed, thioglycollate-elicited macrophages . The reciprocal ofthe dilution of antibody that gives
rise to 50% maximal binding of a fixed quantity of iodinated second antibody is designated
the number of binding units per milliliter. In this assay, 1 mg/ml of pure 5C6 IgG contains
6,300 binding units .
Results
Effect ofmAb 5C6 onDTH after Active Immunization withSRBC.
￿
There is convincing
evidence that the footpad DTH measured in the mouse after intravenous immuni-
zation with a low dose of SRBC is a good model ofTlymphocyte-mediated recruit-
ment of myelomonocytic cells (22-24) . The main features of this DTH are a max-
imal specific response 4 d after active immunization, which reaches a peak at -20 h
after ag challenge . This SRBC-specific response can be transferred systemically
or locally to naive, syngeneic mice only by transfer of cell suspensions containing
Thy-1+, CD4+ lymphocytes from SRBC-sensitized mice (24) . The adoptive DTH
response is not detectable when sensitized T lymphocytes are transferred to mice
that have been lethally irradiated 30 h before transfer . In such recipients in which
thebone marrow and blood myelomonocytic cell pool is depleted, theDTH response
is restored only by the intravenous injection ofbone marrow cells (24) . We have
therefore examined the importance ofCR3-mediated myelomonocytic adhesion in
this immunologically specific inflammatory response .
Fig. 1 shows the increase in footpad thickness seen after local ag challenge with
SRBC 4 d after active systemic immunization . Naive animals (Fig . 1 A) showed
FIGURE 1 .
￿
5C6 inhibited the in-
crease in footpad thickness 20 h
after injection ofSRBC in the loot-
pad4 d after active immunization
with SRBC . (A) Naive mice . (B)
Sensitized mice not treated with
5C6. Intravenous injection of 1 mg
of 5C6 IgG at the time ofSRBC
challenge in the footpad (C) or up to
6h afteragchallenge (D) abolished
the increase in footpad thickness .
Injection of a 10-fold lower dose of
SRBC in the footpad of naive (E)
or sensitized (F)mice illustrated the
dose dependence of the increase in
footpad thickness. 5C6 treatment
abolished the response to lowdose
SRBC in sensitized mice (G) .
Results are the mean t SD of 12
mice pergroup in three separate ex-
periments for (A) to (D). (E, F, and
G) are the mean ± SD of six mice
per group in two separate experi-
ments .538
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a negligible increase in footpad thickness of 0.10 ± 0.05 mm 20 h after ag challenge
compared with the significant increase of 1.26 ± 0.28 mm seen in the footpad size
of the actively immunized control mice (B). The degree ofincreased footpad thick-
ness was dependent upon the amount of ag injected as the high dose of SRBC (108
cells/footpad, B) elicited 2.3 times the swelling seen with a 10-fold lower amount
of ag (0.54 ± 0.16 mm, F). Intravenous injection of 1 mg of 5C6 mAb at the time
of ag challenge completely abolished the footpad swelling seen at 20 h in both high
(C) and low dose (G) ag challenges. Delay of the intravenous injection of 5C6 mAb
for up to 6 h after ag challenge still led to highly efficient inhibition of the footpad
swelling at 20 h (D). The specificity of the 5C6 IgG effect is shown in Table I where
the inhibitory effect of 5C6 IgG on footpad swelling is compared with buffer alone,
a control rat mAb 7/4 binding to circulating myelomonocytic cells with a similar
site number 5C6 (21) or the pepsin F(ab')2 fragment of 5C6, none ofwhich inhibited
footpad swelling. The half-life of injected 5C6 IgG and F(ab')2 was found to be 7.5
and <2 h, respectively.
The ability of 5C6 to inhibit the DTH at 20 h was confirmed on histological ex-
amination ofthe footpadsections. Fig. 2A shows the20-h response to injected SRBC
in a naive mouse. Intact SRBC are seen in the extravasculartissue spaces. Thehost
response to these erythrocytes was minimal with an occasional infiltrating neutro-
phil or monocyte. In contrast, the actively sensitized mouse challenged with SRBC
in the absence of 5C6 mAb shows an obvious inflammatory infiltrate at 20 h, com-
posed of a mixture of monocytes and neutrophils (Fig. 2 B). In actively immunized
mice injected intravenously with 5C6 IgG at the time or up to 6h after ag challenge,
intact SRBC are seen dispersed in the extravascular tissue space without any ac-
companying myelomonocytic inflammatory infiltrate (Fig. 2 C).
The CR3-dependentandCR3-independentRecruitmentofMyelomonocytic CellstoDTH.
￿
Fig.
3 illustrates the time course of thefootpad swelling seen afterag challengeof actively
immunized mice in the presence or absence of 5C6. The control sensitized mice
showed significant increases in footpad thickness within 12 h of ag challenge. This
swelling then reached a peak at 24 h, subsided to 42% of the peak level at 48 h,
and returned to the baseline at 72 h. Mice injected with 5C6 at the time of ag chal-
lenge had an increase in footpad size of 0.08 ± 0.07 mm at 24 h compared with
0.90 f 0.17 mm of the sensitized controls. By 48 h, the 5C6-treated mice had an
TABLE I
Increase in Footpad Thickness 20 h after Antigenic Challenge with SRBC
Assay as described in Materials and Methods. Antibodies (1 mg) were injected
intravenously at the time of ag challenge. Results show the mean t SD of four
mice in each group from one representative experiment.
Immunization
i.v. (day 0)
Challenge
s.c. (day 4) Ab i.v.
Increase in
footpad thickness
mm
PBS SRBC - 0.05 ± 0.05
SRBC SRBC - 1.05 ± 0.10
SRBC SRBC 5C6IgG 0.10 t 0.05
SRBC SRBC 5C6 (Fab)2 0.90 t 0.20
SRBC SRBC 7/4 IgG 1.05 f 0.17ROSEN ET AL .
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FIGURE 2 .
￿
Paraffin-embedded sections ofmurine footpads stained withhematoxylin and eosin .
(A)Naive mouse20 h after injection ofSRBC in footpad. SRBC arrowed . (B) Sensitized mouse
20 h after injection ofSRBC in footpad . Many infiltrating myelomonocytic cells are visible . (C)
Sensitized mouse injected with 5C6intravenously at the time ofSRBC challenge . The myelomono-
cytic cell infiltrate has been abolished . SRBC arrowed . (D) Sensitized mouse 48 h after SRBC
challenge. Very few intact SRBC are visible in the interstitial space and the myelomonocytic
infiltrate remains pronounced. Examination at high power shows many macrophages with en-
gulfedSRBC (arrowed) visible within intracellular vacuoles (E) . (F) Sensitized mouse48 h after
challenge with ag and 5C6IgG at the same time. TheSRBC have persisted at the site of injection
(arrowed) . A small number of myelomonocytic cells have infiltrated the site, mediating the in-
crease in footpad thickness seen at this time .
increase in footpad size of 0.39 t 0.07 mm, which was notdifferent to the declining
increase of0.38 t 0.05 in the untreated sensitized mice . From 48 h onwards, the
curves of the 5C6-treated and the control mice were virtually superimposable . A
second injection of5C6 20 h after ag challenge failed to alter appreciably the late540
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FIGURE 3.
￿
Effect of intravenous
administration of 5C6 on thetime
course of increased footpad thick-
ness in sensitized mice challenged
with SRBC. Results are the mean
± SD of serial measurements of
four mice in each groupperexperi-
ment. Identical results were ob-
tained in three separate experi-
ments.
increase in footpad size seen at 48 h in the 5C6 treated mice. Naive animals injected
with SRBC in the footpad showed no increase in footpad size at any time.
Circulating levels of 5C6 IgG after a single injection of 1 mg IgG were analyzed
by serial dilution of plasma samples. The antiadhesive titer of the mAb was assayed
in vitro usingeither bone marrow neutrophils or elicited M4~ as described (10) and
functionally saturating bloodlevels were maintained for at least 72 h. FAGS analysis
of 5C6 binding to blood, bone marrow,and peritoneal cavity cells after a single in-
travenous injection of5C6 showed that saturation bindingto blood myelomonocytic
cells was achieved within 1 h of injection and maintained for 72 h. At no stage was
any evidence found ofleukocytedepletion, cytotoxicity, or alterations in the differential
blood count. Bone marrow labeling was weak at 1 h, reached saturation by 24 h,
andthen remained stable for the duration of theexperiment. We therefore conclude
that adequate levels of circulating 5C6 IgG were maintained in terms ofboth func-
tional and binding criteria for the duration of the experiment and that inadequate
concentrations of mAb do not account for the failure of 5C6 to inhibit the DTH
at 48 h.
The effect of 5C6 during the time course is once again easily visible on histolog-
ical examination. At 20 h the inhibition of inflammatory recruitment by 5C6 was
complete, as seen in Fig. 2 C. A control footpad from an actively sensitized mouse
examined at 48 h shows a florid inflammatory myelomonocytic infiltrate (Fig. 2 D).
There are very few intact SRBC visible in the tissue spaces and there are many
highly phagocytic cellsfilled with erythrocytedebris (Fig. 2 E). In contrast, the 5C6-
injected mice showed a small inflammatory infiltrate at 48 h that was sufficient to
account for the swelling seen at that time (Fig. 2 F). Most of the ag remained intact
in the extravascular tissue spaces .
We conclude that the recruitmentofmyelomonocytic cellsto thechallenged footpad
is biphasic in actively immunized animals. It consists of an early CR3-dependentROSEN ET AL.
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phase that accounts for most of the footpad swelling and the bulk of inflammatory
cell recruitment. There is a second CR3-independent phase that accounts for the
modest swelling and cellular infiltration seen at 48 h, thetime at whichthe increased
footpad thickness in 5C6-treated and control mice becomes indistinguishable, al-
though obvious differences in both cellular infiltration and ag persistence remain.
LocalandSystemic Administrationof5C6in Naive, SyngeneicMice: EffectsonLocal Transfer
ofDTH. Although CR3 is restricted to the myelomonocytic lineage and is not present
on restingor activated lymphocytes(10), it is important to demonstratethat the 5C6
mAb limits its effects to inhibition of myelomonocytic recruitment and does not im-
pair the ability of Tlymphocytesto become activated and to transfer DTH. To assess
the effects of 5C6 on the development of functional sensitized T cells, mice were
injected intravenously with 5C6 and then immunized with SRBC. 4 d later, sensi-
tized T cells were harvested, washed by centrifugation, mixed with SRBC, and in-
jected into the footpad of naive, syngeneic mice. Table 11 shows that the footpad
swelling seen afterpassive transfer of ag and blood leukocytes was similar usingdonor
leukocytes recovered from mice immunized with SRBC in the presence or absence
of systemic 5C6.
We also examined the effect of 5C6 injection in recipient mice on hypersensitivity
following passive local transfer of SRBC-reactive T cells and SRBC. Local transfer
led to acute onset of DTH and reached a peak at 15 h after ag challenge.
Table H showsthat local transfer to naive, syngeneic recipients of sensitized blood
leukocytes mixed with SRBC led to an increase in footpad size of 0.52 t 0.05 mm
in control mice at 15 h while leukocytes or ag alone failed to elicit any response.
TABLE II
mAb 5C6 Inhibits T Cell-dependent Myelomonocytic Recruitment
but not ag-dependent T Cell Priming or Activation
Performed as described in Materials and Methods. Results reflect the mean t SD offour mice
per group. Equivalent results were obtained in each of two separate experiments.
Treatment (donors) Transfer to recipients
Increase footpad
thickness (recipients)
at 15 h
Mm
PBS Blood leukocytes
SRBC 0.10 t 0.05
Blood leukocytes + SRBC
SRBC Blood leukocytes
SRBC
0.10 t 0.05
Blood leukocytes + SRBC 0.52 t 0.05
Blood leukocytes + SRBC 0.10 f 0.08.
Recipients treated 5C6 IgG i.v.
Blood leukocytes + SRBC 0.58 t 0.09
Transferred cell preincubated
5C6 and washed before transfer
SRBC + 5C6 IgG Blood leukocytes
SRBC
0.08 t 0.06
Blood leukocytes + SRBC 0.65 t 0.12542
￿
ANTI-CR3 INHIBITS ANTIGEN-SPECIFIC INFLAMMATION
If mice were injected with 5C6 intravenously at the time of local transfer of sensi-
tized cells and ag, increase in footpad size was significantly diminished at 0.10 ±
0.08mm at 15 h . This result was confirmed by histologic observation (data not shown) .
Effect of5C6on Adoptiae Transfer ofTCell-dependent In J7ammatory Reaction to Tuberculin.
The effect of 5C6 was not restricted to inhibiting T cell-dependent recruitment of
inflammatory cells to one ag alone at a single anatomical site . We have analyzed
recruitment of monocytes to the peritoneal cavity after simultaneous injection of
BCG-sensitized T lymphocytes and tuberculin . This system has the advantage of
allowing sampling ofperitoneal cells and accurate assessment of the number ofinflam-
matory cells recovered . We chose to examine the cellular response at 2 d to highlight
the CR3-dependent recruitment of monocytes .
Fig . 4 shows the effects of5C6 on inflammatory recruitment after transfer of sen-
sitized lymphocytesand tuberculin to the peritoneal cavity of naive, syngeneic mice .
Naive mice not injected with cells or ag, or injected with either cells or ag alone,
yielded 4.65 ± 1 .68 x 106 peritoneal leukocytes of which 45% (2 .1 x 106 ) were M(b
by virtue of their expression of the F4/80 ag by immunocytochemistry . 2% were
neutrophils and 53% lymphocytes . 48 h after transfer of 1.5 x 10' BCG-sensitized
lymph node cells and 50 ug tuberculin, the number of peritoneal cells had increased
to 9.12 ± 2.29 x 106 cells, of which 66% (6.10 x 106) were M$, 8% neutrophils,
and 26% lymphocytes . In contrast, mice treated by the intravenous injection of5C6
at the time of transfer of sensitized cells and tuberculin had only 4.28 ± 2 .22 x
106 peritoneal leukocytes at 48 h of which 47% (2 .01 x 10 6) were M4~, 3% neutro-
phils, and 50% lymphocytes . Injection of tuberculin alone failed to elicit any quan-
titative or qualitative changes in the recovered cell population . The cellular response
to the local injection of BCG-sensitized T cells mixed with tuberculin was predomi-
nantly monocytic in nature and was completely inhibited by the intravenous injec-
tion of 5C6 mAb, if the initial resident population is taken into account .
Discussion
These studies in which we have inhibited the DTH in vivo using a CR3-specific
mAb highlight a role for CR3 in T cell-dependent recruitment of myelomonocytic
leukocytes . These data extend our observations that an mAb restricted to the CR3
FIGURE 4 .
￿
mAb 5C6 inhibited recruitment of mono-
cytes to the peritoneal cavity after passive transfer ofsen-
sitized lymph node cells and tuberculin . Mice treated
with sensitized lymph node cells or tuberculin alone had
the same number of F4/80' peritoneal cells as control
animals . Injection of both sensitized Bells and tuberculin
caused recruitment of monocytes which was abolished
by 5C6 injection at the time of transfer. Results show
the mean t SD offour mice per group, in one of two
identical experiments .ROSEN ET AL.
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can inhibit leukocyte responses to thioglycollate broth (10). There is no evidence
in either of these experimental models that 5C6 IgG functions in vivo by cytotox-
icity or the depletion of myelomonocytic cells from blood or bone marrow. Its in-
hibitory effects in vivo correlate thus far with its in vitro inhibition ofCR3-dependent
adhesion and spreading (10). We conclude that CR3 is important either directly or
indirectly in the migration of myelomonocytic cells to inflammatory sites in both
immunologically specific and nonspecific processes. The mechanism(s) by which the
mAb achieves this inhibition of recruitment remain(s) unclear.
5C6 Inhibition of the Early Phase ofDTH .
￿
5C6 efficiently inhibits the first 24 h of
the DTH to SRBC with respect to the parameters of footpad swelling and myelo-
monocytic cell recruitment on histological section. This effect is specific for the 5C6
IgG and is absent using the F(ab')2 pepsin fragment capable of blocking iC3b
binding, but not nonspecific inflammation (10). The F(ab')2 fragment is rapidly
cleared after injection with a half-life of <2 h, unlike the IgG with its 7.5-h half-life.
This rapid clearance is similar to that described for rabbit antibodies and fragments
(25). Inhibition of recruitment with the F(ab')2 might require constant infusion to
maintain adequate circulating levels. The myelomonocytic-restricted 7/4 mAb had
no inhibitory effects on either footpad swelling or cellular infiltration.
After 24 h the inhibitory effects of 5C6 were less evident with gradual swelling
of the footpad to -40% of the peak swelling seen in the control group at 48 h and
then returning to normal by 72 h . This swelling was accompanied by limited infiltra-
tion of both neutrophils and monocytes to the site of injection, though removal of
SRBC was limited. Functional adhesion assays and monitoringofcell labeling using
FAGS showed that adequate levels of 5C6 were maintained in both intravascular
and bone marrow leukocyte compartments throughout the duration of the experi-
ments. The time course ofthe DTH response is therefore consistent with a biphasic
process, a first CR3-dependent recruitment phase that peaks at 24 h and then sub-
sides, while the second phase appears CR3-independent and rises after 24 h to reach
a lower peak at 48 h .
A possible explanation for the failure of 5C6 to inhibit swelling at 48 h is that
CR3 may not be the sole cell adhesion molecule that can mediate migration of my-
elomonocytic cells to a T cell-dependent inflammatory site. Local persistence of a
particulate ag such as SRBC and the presence of additional recruitable sensitized
T cells may lead to the prolonged production of T cell secretory products such as
IFN-y, that with time may alter or induce expression of ligands on the adjacent en-
dothelial cell surfaces for other leukocyte adhesion molecules. Candidate leukocyte
receptors include LFA-1 (26), p150,95 (27), members of the VLA family (28), mono-
cyte IIb-IIIa (29), and possibly MEL-14 (30), while molecules such as ICAM-1 (31)
and ELAM-1 (32) are potential endothelial surface ligands. These possibilities should
be examined in vitro and in vivd~usingrecombinant cytokines and other mediators.
Another possibility is that T cell products lead to damage to the endothelial monolayer
and expose the basement membrane. Myelomonocytic cells with their well-documented
abilities to bind substratum components such as fibronectin (33) and laminin should
then be able to leave the vascular compartment. 5C6 does not impair the adhesion
of M4~ or neutrophils to fibronectin (10).
Although in the present studies we found a marked difference in T cell-depen-
dent myelomonocytic recruitment in mice treated with an anti-CR3 mAb, altered544
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DTH responses have not been deemed to be a prominent feature of leukocyte adhe-
sion deficiency (LAD) in man. Anderson et al. (34) found a positive cutaneous hyper-
sensitivity response to Candida albicans antigens in two of three patients with severe
deficiency of the LFA-1 family glycoproteins. The remaining patient with severe
deficiency was reported to have had a negative Candida skin test. Patients with
moderate deficiencies tended to have positive responses to Candida and the one
reported biopsy of a Candida test showed perivascular infiltration by mononuclear
leukocytes similar to the stromal infiltration seen in a gingival biopsy from the same
patient. The SRBC model, while being a good T cell-dependent model of inflam-
mation, differs from the DTH in humans in a number of important respects. The
cells recruited are myelomonocytic rather than monocytic, the window during which
sensitized T cells are circulating is narrow, and the response is characterized by rapid
swelling and relatively rapid resolution without prolonged induration . Furthermore,
comparison with the findings in the human patients is hampered by the absence
of published data on the nature or extent of the infiltrate in the indurated areas of
cutaneous hypersensitivity. It will be important to extend present studies to other
DTH models in the mouse, and to investigate the time course and extent of the DTH
response in the human LAD patients.
5C6Inhibition ofLocal Transfer ofDTHto SRBC in Naive, Syngeneic Mice.
￿
We used
passive transfer ofDTH to restrict the experiment to the examination of myelomono-
cytic cell recruitment alone. The failure of 5C6 injection in donor mice at the time
of sensitization to have any effect on transfer of DTH to recipients, rules out the
possibility that 5C6 acts by interfering with T cell sensitization. The inhibitory effect
of systemically injected, but not of locally injected 5C6, reinforces the notion that
5C6 acts only at the level of myelomonocytic cells and not on lymphocyte migration
or reactivation at the local site. 5C6 inhibition of the local transfer was complete
and the second CR3-independent phase of recruitment and footpad swelling found
in the actively immunized mice was not present. The passive transfer experiments
are thus a simplification of the model .
5C6Inhibition ofMonocyte Recruitment to Locally Transferred Sensitized TCells and Tuber-
culin. The inhibition of DTH to tuberculin provides important additional data.
First, it shows that the role of CR3 is not restricted to specific recruitment of myelo-
monocytic cells to one ag alone. Second, unlike DTH to SRBC, our data from the
DTH response to tuberculin in the peritoneal cavity show that it is predominantly
monocytic rather than a neutrophil-rich mixture of myelomonocytic cells. This more
closely resembles the DTH response in the human . Under these experimental con-
ditions, as in the passive transfer of DTH to SRBC, 5C6 IgG causes almost com-
plete inhibition ofthe DTH response even after 48 h with no CR3-independent phase.
Treatment with 5C6 mAb also allowed the separation of the resident and recruited
peritoneal leukocyte populations with only resident cell numbers being recovered
after 5C6 treatment.
The present study implicates CR3 as a significant molecule in the T lymphocyte-de-
pendent recruitment of myelomonocytic cells to an inflammatory site, while not
elucidating the mechanism by which CR3 acts in these models . The precise role
of CR3 could be revealed by mAbs that show functional inhibition in vivo as monova-
lent fragments, although the rapid clearance of such fragments might pose technical
difficulties in performing such experiments. Such reagents are currently being sought.ROSEN ET AL .
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This study extends previous observations by ourselves (10) and others using reagents
directed against either the specific a chain ofCR3 (35, 36) or the common LFA-1
R chain (37-39) that CR3 is critical in the genesis of nonspecific inflammatory re-
sponses . We have highlighted the potential of the CR3 as a target for antiinflamma-
tory drug therapy likely to be useful in a range of clinical conditions characterized
by a deleterious inflammatory process, irrespective of whether such inflammation
is immunologically specific or not . There will, however, also be a range ofT cell-de-
pendent responses, including transplant rejection and the response to viral pathogens
where the contribution of CR3 is of lesser importance (Rosen, H ., and S . Gordon,
unpublished observations) . Impairment ofCR3-dependent myelomonocytic recruit-
ment in animals mounting a cell-mediated immune response to a rapidly prolifer-
ating organism such as Luteria monocytogenes can also be profoundly deleterious (Rosen,
H ., S . Gordon, and R . J . North, manuscript in preparation), indicating that the
use of such a strategy to inhibit inflammation should be treated with caution .
Summary
We have used the delayed-type hypersensitivity (DTH) response to SRBC or tuber-
culin to examine the role of the murine type 3 complement receptor in T lympho-
cyte-dependent inflammatory recruitment . Intravenous injection of 5C6, a CR3-
specific rat mAb known to impair myelomonocytic adhesion, divided the DTH to
SRBC in actively immunized mice into two phases . The early phase, which lasted
24 h, was characterized by maximal oedema and maximal inflammatory recruit-
ment and was 5C6 inhibitable . The later phase was 5C6 resistant and reached a
peak 48 h after antigenic challenge and was superimposable on the declining peak
seen in control mice . Passive transfer of reactiveT cells mixed with antigen was used
to examine the myelomonocytic effectorarm ofthe DTH alone . Both passive transfer
of cutaneous DTH toSRBC and passive transfer ofthe largely monocyticT cell-de-
pendent recruitment to tuberculin in the peritoneal cavity were completely abol-
ished by systemic 5C6 treatment . Injection of 5C6-treated donor leukocytes at the
site of passive transfer had no effect . Treatment ofdonor mice with 5C6 at the time
of active immunization did not alter their ability to provide reactive T cells for pas-
sive transfer. The myelomonocyte-restricted rat mAb 7/4 and the rapidly cleared
F(ab')2 fragment of 5C6 showed no inhibition of the DTH . In all cases, inhibition
offootpad swelling correlated with histological evidence of inhibition ofmyelomono-
cytic cell recruitment . Peritoneal cell counts after local DTH to tuberculin showed
complete inhibition ofmonocyte recruitment . We conclude that CR3 plays a quan-
titatively important role in T cell-dependent inflammatory recruitment . This is ab-
solute in passive transfer experiments, but only partial after active immunization .
Leukocyte CR3 plays acommon role in both immunologically specific and nonspecific
inflammatory recruitment and provides a target that could possibly be manipulated
to therapeutic advantage.
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